Phase I Clinical Trials at
Nebraska Cancer Specialists

Nebraska Cancer Specialists is one of only a small group of leading community oncology practices in the country to offer an array of phase 1 trials.

 

Phase I trials generally evaluate the safety of a new drug or new combinations of drugs. Typically they involve a small number of patients for whom standard therapies have proven ineffective and seek to determine a safe dose level and obtain a preliminary assessment of efficiency. Patients benefit from a range of trials that would typically only be found at large academic research centers, but offered in the convenience and personal care of a private practice.

 

Our robust Research Department is helping advance cancer research, while offering hope to patients fighting the toughest battles. Through phase I trials, we are able offer first ever access to clinical trial treatments and therapies. Our research department has experience in delivering first-in-human drug trials including studies in which we have treated the first patient ever with new drugs.

 

When a patient is deemed eligible for a phase 1 trial, they experience an added level of care. In addition to our standard oncology team of physicians, nurse practitioners and case managers, patients in phase I trials will be working closely hand-in-hand with our Research Team.

 

Send us a note to discuss available clinical trial options for you.

For a list of available trials, contact Megan Meays, Research Director | mmeays@nebraskacancer.com

 

For a list of 100+ available clinical trials, contact Megan Meays, Research Director | mmeays@nebraskacancer.com

 

Want to Know More?

We are hear to help! If you are interested in learning more about Nebraska Cancer Specialists’ phase 1 trials, please contact our Research Director.

Contact Us for More Information